2 Biotech Stocks Experiencing Significant Sell-Offs Investors Should Avoid

2 Biotech Stocks Experiencing Significant Sell-Offs Investors Should Avoid
On Thursday November 8th, two companies within the biotech sector announced significant news that should send shares lower over the next few trading sessions. Both of these companies should be considered potential candidates for the establishment of a …
Read more on Seeking Alpha

Biotech Stock Mailbag: More Amarin, MannKind, Orexigen
BOSTON (TheStreet) — Welcome to the end of a crazy week. Some of you are still dealing with the lack of electricity or damage caused by Hurricane Sandy, but here's hoping the weekend starts to bring some relief.
Read more on TheStreet.com

Oncolytics Biotech® Inc. Announces Third Quarter 2012 Results
8, 2012 — /PRNewswire/ – Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY) ("Oncolytics" or the "Company") today announced its financial results and operational highlights for the quarter ended September 30, 2012. "We continue to make progress …
Read more on Sacramento Bee

Leave a Reply